Copper peptides for skin: what the science says vs. TikTok hype

What did @sarahbabula actually say?

Sarah ran through five topical peptide serums she considers science-backed picks across a range of budgets. She praised "targeted delivery systems" in the Educated Mess serum, called the Medicaid (likely The INKEY List or a similar brand) original a baseline, highlighted Peach and Lily's new Exosome Serum for its peptide density, and flagged a budget option at $19 from Turium that she says uses a "targeted copper peptide" and liposomal encapsulation.

She also made a point worth paying attention to: she said she "doesn't think exosomes can be stabilized at room temp in solution," which is a real formulation concern, not just speculation. She framed the whole thing as her personal opinion but called it "science-packed." That claim deserves some scrutiny.

Does the science back this up?

Partially, yes. Topical peptides are genuinely studied, but the evidence base is thinner and messier than most skincare creators let on. Copper peptide GHK-Cu has the most support for skin remodeling, with studies like Pickart and Margolina (2018, Cosmetics) showing it can stimulate collagen synthesis and wound healing in cell and animal models. But human RCT data is still limited.

On delivery systems: Sarah is right that encapsulation matters. Peptides are large, charged molecules that struggle to penetrate the stratum corneum without help. Liposomal and nanoparticle delivery has been shown to improve penetration in research settings (Gendler, 2020, Journal of Drugs in Dermatology). Her point that smaller peptides penetrate more easily due to molecular size is also accurate, grounded in the 500-dalton rule of skin absorption. However, claiming that specific commercial formulations achieve this in practice is harder to verify without independent testing data, which she doesn't provide.

What did they get wrong (or right)?

She got the exosome skepticism right, and that deserves credit. Stabilizing exosomes in aqueous solution at room temperature is a genuine unsolved problem in cosmetic formulation. Exosomes are lipid-bilayer vesicles that degrade rapidly outside controlled conditions. Researchers like Witwer and Buzas (2021, Nature Reviews Drug Discovery) have flagged stability and standardization as core challenges even in clinical-grade exosome products. Most over-the-counter exosome serums are almost certainly not delivering intact, functional exosomes.

Where Sarah falls short: she doesn't cite any specific studies, she doesn't disclose whether she has any financial relationships with these brands, and she conflates "advanced complexes" with proven outcomes. Saying a product has "so many targeted delivery systems" is a description of ingredient lists, not evidence of clinical effect. The jump from formulation sophistication to skin benefit is not automatic, and she doesn't acknowledge that gap.

What should you actually know?

Topical peptide serums are a legitimate category with real but modest evidence behind them. GHK-Cu is the peptide with the strongest published record for skin applications. Delivery technology matters, liposomes and encapsulation do improve penetration in controlled studies, but whether a $19 product achieves this as effectively as a more expensive one is genuinely unknown without head-to-head data.

The exosome serum market is largely unregulated and the claims around it routinely outpace the science. Sarah is one of the few creators who actually flagged this, which puts her ahead of most. But product recommendations from someone identifying as a chemist, without conflict-of-interest disclosures, should still be treated as a starting point for research, not a final word. If you are interested in peptide-based skincare, look for products that list GHK-Cu, palmitoyl tripeptide-1, or acetyl hexapeptide-3 with published safety profiles, and manage expectations. These are cosmetics, not drugs, and regulatory standards for efficacy claims are low.